1060816-39-8Relevant articles and documents
ALPHA-SYNUCLEIN LIGANDS
-
Paragraph 0250, (2017/08/01)
The present invention generally relates to various compounds that are useful as α-synuclein ligands. The invention further relates to methods of using these compounds and their radiolabeled analogs for the detection of synucleinopathies, including Parkinson's disease (PD).
HETEROCYCLIC COMPOUNDS AND USES THEREOF
-
Paragraph 00655; 00659; 00709, (2015/04/22)
Compounds and pharmaceutical compositions that modulate kinase activity, including PI3 kinase activity, and compounds, pharmaceutical compositions, and methods of treatment of diseases and conditions associated with kinase activity, including PI3 kinase activity, are described herein.